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ABSTRACT
Objective: The study aimed to investigate gene mutations in Mycobacterium tuberculosis causing resistance to rifampicin (RIF) in multidrug resistance 
TB patients in Haji Adam Malik Hospital and determined the suitability of the general pattern of mutations that occur in patients with multidrug-
resistant TB (MDR-TB) in the hospital with global mutation pattern.
Methods: This observational study was performed prospectively in 31 patients with MDR-TB who had data medical record results of GeneXpert MTB/
RIF positive for resistant to RIF period August–November 2016 in the hospital by taking sputum from patients. DNA extracted from sputum and then 
purified to be detected using polymerase chain reaction (PCR). PCR products were examined by electrophoresis.
Results: The highest percentage of 81 bp rpoB gene mutation MTB is called as RIF -resistance determining region which was located at codon 
516 (100%) and then was followed by mutation at codon 531 (96.77%) and codon 526 (90.32%), respectively, while the smallest percentage of 
mutation (12.90%) MTB at codon was 533.
Conclusion: The rpoB gene shows a positive mutated causes resistance to rifampicin to RIF.
Keywords: Multidrug resistance tuberculosis, Mutations, Gene rpoB, Polymerase chain reaction.
INTRODUCTION
Tuberculosis (TB) treatment is inseparable from multidrug-resistant 
TB (MDR-TB), a condition where TB patients cannot be treated with a 
first-line anti-TB drug regimen, because resistance to rifampicin (RIF) 
and isoniazid has occurred with or without resistance to other anti-
TB drugs. Globally, of 6.3 million TB patients, as many as 5% of them 
(+300,000 cases) have been detected with MDR-TB. Facts indicated that 
from 480,000 patients with MDR-TB caused 190,000 of deaths [1,2].
Based on MDR-TB Global Report 2010, Indonesia is a country with 
the eight highest burden of MDR-TB in the world with estimated cases 
of new MDR-TB as many as 8900 people per year [3]. Meanwhile, 
according to the WHO data in 2013, Indonesia has been ranked as the 
9th highest prevalent of 30 countries. [3]
According to Rattan in MDR-TB molecular perspectives, genetic 
analysis and drug resistance molecules in MDR-TB show that resistance 
is usually obtained from bacilli with changes in drug targets through 
mutation or through an excess of drug titration to the target. MDR-TB 
is mainly due to the accumulation of individual gene mutations of RIF 
drug target reported in the rpoB gene that produces B-subunit RNA 
polymerase (>95% of resistant strains) [4].
Research on conservative areas of mutation in MTB has not been 
widely practiced in Indonesia. Therefore, this study aimed to identify 
mutations in the rpoB MTB gene that includes the RIF resistance 
determining region (RRDR) area using the polymerase chain reaction 
(PCR) multiplex method. The results of this study are expected to help 
the development of molecular techniques in MDR-TB diagnosis in 
Indonesia in particular.
MATERIALS AND METHODS
This research procedure has received permission from the Ethics 
Committee of the Faculty of Medicine, University of Sumatera Utara/
RSUP H. Adam Malik, and the patients included in the research have 
signed the written informed consent.
MATERIALS
The materials used as samples in this study were sputum obtained from 
31 patients with MDR-TB admitted to RSUP H. Adam Malik Medan. The 
chemicals used were 4% NaOH, sterile phosphate buffer pH 6.8, DNA 
extract kit PureLink ™ Genomic DNA, PBS (Phosphate Buffer Saline), GoTaq® 
Green Master mix, DMSO, nuclease-free water, M. TB H37RV, agarose gel 
(Invitrogen), TAE ×10 (Invitrogen) buffer, ethidium bromide, and BenchTop 
1000 bp DNA ladder (Promega). Instrument used in this experiment was 
PCR Thermal Cycler (Applied Biosystem Veriti 96 well, Temecula, California).
Extraction and purification of MTB DNA from standard sputum 
and strain H37RV
DNA extraction and purification of MTB samples and standard strains of 
H37RV as a positive control were performed using PureLink™ Genomic 
DNA (Invitrogen) with procedures according to the manufacturer.
Amplification of rpoB gene codons 516, 526, and 531 multiplex-
PCR [5]
5 µL DNA extract was added with 12.5 µL of GoTaq® Green Master mix, 0.5 µL 
of DMSO, 3 µL of nuclease-free water, and primer rpoB codons 516, 526, 
and 531 (Table 1) each 1 µL in PCR tube, then amplification the samples 
on PCR Thermal cycler machines under conditions as shown in Table 2. 
PCR products were examined by electrophoresis gel. Wild-type MTB 
H37RV will form DNA bands measuring 218 base pair (bp), 185 bp, and 
170 bp, and a sample is said to be mutant if no DNA bands are formed in 
218 bp, 185 bp, and 170 bp or one of those DNA bands.
Amplification of rpoB gene codons 507, 518, and 533 multiplex-
PCR [5]
5 µL DNA extract was added with 12.5 µL of GoTaq® Green Master mix, 
0.5 µL of DMSO, 3 µL of nuclease-free water, and primer rpoB codons 
507, 518, and 533 (Table 3) each 1 µL in PCR tube, then amplification of 
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rpoB gene fragments on PCR Thermal cycler machines under conditions 
as shown in Table 2. PCR products were examined by electrophoresis 
gel. Wild-type M. TB H37RV will form DNA bands measuring 244 bp, 
213 bp, and 163 bp, and a sample is said to be mutant if no DNA bands 
are formed in 244 bp, 213 bp, and 163 bp or one of those DNA bands.
Amplification of rpoB gene codons 511, 513, and 522 multiplex-
PCR [5]
5 µL DNA extract was added with 12.5 µL of GoTaq® Green Master mix, 
0.5 µL of DMSO, 3 µL of nuclease-free water, and primer rpoB codons 
511, 513, and 522 (Table 4) each 1 µL in PCR tube, then amplification of 
rpoB gene fragments on PCR thermal cycler machines under conditions 
as shown in Table 2. PCR products were examined by electrophoresis 
gel. Wild-type MTB H37RV will form DNA bands measuring 230 bp, 
251 bp, and 199 bp, and a sample is said to be mutant if no DNA bands 
are formed in 230 bp, 251 bp, and 199 bp or one of those DNA bands.
Detection of PCR results by agarose gel electrophoresis [6]
A total of 3.9 g of agarose in 130 mL trisasetate EDTA (TAE) ×10 was 
heated until dissolved, and then, the solution was kept warm and added 
1 µL ethidium bromide (EtBr). The mixture was shaken until homogen 
and then poured into the mold and allowed to freeze completely. A total 
of 5 µL PCR and marker samples were incorporated into a 3% agarose 
gel well. The electrophoresis process was performed with a potential 
difference of 80 V, 400 A for 70 min. The DNA of the electrophoretic 
amplification was visualized using gel documentation. The DNA bands 
will be visible and can be measured according to the molecular size 
marker expressed by the base pair.
RESULTS
Based on the distribution of mutation of rpoB MTB gene in the study 
subjects, all samples had mutation of rpoB MTB gene at codon 516 (100%), 
and no wild-type MTB was found. Of 31 samples, 30 people (96.77%) had 
mutations of rpoB gene in multiple codons (multiple mutations), and only 
1 sample had mutated rpoB MTB gene at codon 516 (Table 5).
The highest percentage of gene mutation of 81 bp rpoB MTB or at RRDR 
area was at codon 516 (100%), followed by codon 531 (96.77%) and 
codon 526 (90.32%). The smallest percentage of 81 bp rpoB MTB gene 
mutation was present at codon 533 (12.90%). This mutation occurrence 
is similar to the research of Da Silva and Palomino [7], and the most 
frequent mutations in codons 531, 526, and 516 often reported in most 
studies [7,8]. The mutations found in this study were consistent with the 
study found by Lingala et al. [9] in India that the 81 bp rpoB MTB gene 
mutation was found in codon 531 (47%), 526 (17%), and 516 (13%). 
While Yao in 2010 used isolates from Chongqing, China, the percentage 
of 81 bp rpoB MTB gene mutation occurred at codon 531 (73%) and 
codon 513 (27%), but no mutations were found in codons 511, 516, 
526, and 533 [10]. Nghiem’s [11] study using the Vietnamese isolate 
MTB also showed similar results with Lingala et al. findings in India 
with the highest percentage of rpoB mutations at codon 531 (37.8%), 
526 (23%), and 516 (9, 46%).
The PCR product was examined by gel electrophoresis. Wild-type MTB 
H37RV as a positive control will form the specific fragment of the 
allele according to the primary target used, whereas the PCR multiplex 
sample results are said to mutate if no DNA bands are formed according 
to the specific fragment of the allele, which is validated with positive 
control and the negative controls used. Both controls performed well, 
indicated by the absence of DNA bands on negative PCR control results 
and the presence of DNA bands according to PCR multiplex performed 
on positive PCR control results. The electrophoretic results of PCR 
products resistant to RIF are shown in Figs. 1-4.
DISCUSSION
RIF resistance is associated with mutations in the rpoB gene, which 
encodes the β-subunit of MTB RNA polymerase [12]. With GeneXpert 
MTB/RIF, the resistance to RIF is detected as failure of one or more specific 
Table 1: Primer used for rpoB gene amplification codons 516, 
526, and 531 multiplex-PCR and detection of MDR strains MTB
Target Primer Sequence (5’-3’) Product 
size (base 
pair)
rpoB 516 rpoB 516 CAGCTGAGCCAATTCATGGA 218
RIRm TTGACCCGCGCGTACAC
rpoB 526 rpoB 526 CTGTCGGGGTTGACCCA 185
RIRm TTGACCCGCGCGTACAC
rpoB 531 rpoB 531 CACAAGCGCCGACTGTC 170
RIRm TTGACCCGCGCGTACAC
PCR: Polymerase chain reaction, MDR: Multidrug-resistant, 
MTB: Mycobacterium tuberculosis
Table 3: Primer used for rpoB gene amplification codons 507, 
518, and 533 multiplex-PCR and detection of MDR strains MTB
Target Primer Sequence (5’-3’) Product 
size (base 
pair)
rpoB 507 rpoB 507 GCGATCAAGGAGTTCGG 244
RIRm TTGACCCGCGCGTACAC
rpoB 518 rpoB 518 TGAGCCAATTCATGGACCAGA 213
RIRm TTGACCCGCGCGTACAC
rpoB 533 rpoB 533 CGCCGACTGTCGGCGCT 163
RIRm TTGACCCGCGCGTACAC
PCR: Polymerase chain reaction, MDR: 
Multi-drug-resistant, MTB: Mycobacterium tuberculosis
Table 4: Primer used for rpoB gene amplification codons 511, 
513, and 522 multiplex-PCR and detection of MDR strains MTB
Target Primer Sequence (5’-3’) Product 
size (base 
pair)
rpoB 511 rpoB 511 TTCGGCACCAGCCAGCT 230
RIRm TTGACCCGCGCGTACAC
rpoB 513 rpoB 513 CACCAGCCAGCTGAGCC 251
RIRm TTGACCCGCGCGTACAC
rpoB 522 rpoB 522 GACCAGAACAACCCGCTGT 199
RIRm TTGACCCGCGCGTACAC
PCR: Polymerase chain reaction, MDR: Multi-drug-resistant, 
MTB: Mycobacterium tuberculosis
Table 5: Distribution of mutations of rpoB MTB gene in the 
study subjects










Wild type 0 (0.00)
n was number of samples, MTB: Mycobacterium tuberculosis
Table 2: Multiplex PCR thermal cycler genes rpoB
Initial denaturation 5 min 95°C
40 cycles
Step 1 30 sec 95°C
Step 2 30 sec 68°C
Step 3 30 sec 72°C
Final extension 7 min 72°C, PCR: Polymerase chain reaction
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Fig. 1: Electrophoresis of polymerase chain reaction (PCR) 
products 213 bp and 163 bp of rpoB MTB gene fragments with 
primers rpoB518, rpoB533, and RIRm in agarose 3%. Lane A: 
1000 bp DNA Ladder/M  arker; Lanes 1 and 28: negative controls; 
Lanes 2 and 29: H37RV wild-type PCR results (positive control); 
Lanes 3–27 and 30–35: PCR result sample 1–31
Fig. 2: Electrophoresis of polymerase chain reaction (PCR) 
product 251 bp and 230 bp of rpoB MTB gene fragment with 
primer rpoB511, rpoB513, and RIRm in agarose 3%. Lane A: 
1000 bp DNA Ladder/Marker; Lanes 1 and 28: negative controls; 
Lanes 2 and 29: H37RV wild-type PCR results (positive control); 
Lanes 3–27 and 30–35: PCR result sample 1–31
Fig. 3: Electrophoresis of polymerase chain reaction (PCR) 
product 218 bp, 185 bp, and 170 bp of rpoB MTB gene fragment 
with primer rpoB516, rpoB526, rpoB531, and RIRm in agarose 
3%. Lane A: 1000 bp DNA Ladder/Marker; Lanes 1 and 28: 
negative controls; Lanes 2 and 29: H37RV wild-type PCR results 
(positive control); Lanes 3–27 and 30–35: PCR result sample 1–3
Fig. 4: Electrophoresis of polymerase chain reaction (PCR) 
product 244 bp and 199 bp of rpoB MTB gene fragment with 
primer rpoB507, rpoB522, and RIRm in agarose 3%. Lane A: 
1000 bp DNA Ladder/Marker; Lanes 1 and 28: negative controls; 
Lanes 2 and 29: H37RV wild-type PCR results (positive control); 
Lanes 3–27 and 30–35: PCR result sample 1–31
rpoB-molecular beacons to hybridize the rpoB polymorphism amplicon 
and most commonly in codons 516, 526, and 531. Some studies show that 
95% of MTB who are resistant to RIF have mutations in the 81bp rpoB 
gene at codons 507–533 [12,13]. An estimated 5% of MTB that is resistant 
to RIF has mutations outside the hotspots of the rpoB region [12].
Mutation of the rpoB MTB gene at codon 516 has been reported to 
occur Asp516 mutation to Val and Gly, the residue termination into 
Val and Gly causes the hydrogen bond not formed, and the amino acid 
residue change with polar side chain becomes non polar. The loss of the 
initially formed hydrogen bonds reduces the binding affinity of the RIF 
so that the RIF is weaker in the RNAP β subunit, consequently the RIF 
cannot work effectively, whereas the RIF activity is more dependent on 
its ability to bind to RNAP. In addition, rigid RIF conformations are also 
suspected to cause RIFs to adapt to mutations that alter the shape and 
chemical environment of the bonding site. If the RIF is weakly bound to 
RNAP, it results in a change of RIF position, especially in dynamic enzyme 
conditions and also influenced by the presence of water molecules. 
When the RIF position changes in such a way that it no longer blocks 
the RNA extension path, it is likely that the transcription process will 
continue to run and the bacteria will be resistant to RIF [14].
One study of the rpoB gene in RIF -resistant isolates has identified 
various short mutations and deletions in genes. Of the reported studies, 
there were 69 single nucleotide changes, 3 insertions, 16 deletions, and 
38 multiple nucleotide changes. Over 95% of all mutations are located 
at 81bp of the rpoB gene core region between codon 507 and 533 
with the most frequent changes in the Ser531Leu codon, His526Tyr, 
and Asp516Val. Serine amino acid changes at codon 531 and histidine 
at codon 526 were found in 70% of RIF -resistant isolates [10,11]. 
However, further research is needed to confirm the amino acids that 
are mutated in the results of this study through sequencing.
Based on the theory, if the resistance of RIF and MDR of TB has a 
strong correlation, then the detection of MDR TB is sufficient only with 
single rapid test that detects RIF resistance such as GeneXpert MTB/
RIF. In countries with low RIF monoresyant events but high TB MDR 
prevalence, this correlation can be used. In countries with high RIF 
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monoresistant events, the correlation is questionable and not always 
usable [15]. Based on data from the WHO [3], Indonesia is one of the 
countries with high TB burden of MDR with estimated MDR-TB patients 
of 6,900 cases, i.e., 1.9% of new cases and 12% of re-treatment cases. 
Therefore, GeneXpert MTB/RIF can be used to detect or diagnose MDR-
TB for cases in Indonesia.
CONCLUSION
The highest percentage of gene mutation 81 bp rpoB MTB or RRDR is 
located at codon 516 (100%) then at codon 531 (96.77%) and codon 
526 (90.32%), while the smallest percentage of the gene mutation 
81 bp rpoB MTB at codon 533 (12.90%).
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